...
首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome
【24h】

Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome

机译:STAT3和STAT5活性的调节可纠正急性冠脉综合征患者Th17和Treg细胞的失衡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The signal transducer and activator of transcription (STAT) activity plays an important role in the differentiation and imbalance of Th17 and Treg cells in acute coronary syndrome (ACS) patients. We determined that the basal STAT3 phosphorylation level was significantly increased and exhibited a positive relationship with Th17 cells but was negatively correlated with Treg cells in ACS patients. Opposite effects were observed for STAT5 activity. Using the pharmaceutical inhibitor TG101348 or knockdown of STAT3 reduced the number of Th17 cells while promoting the number and function of Treg cells via the Janus kinase2 (JAK2)/STAT3 pathway in ACS patients. Significantly more STAT5 bound to the Foxp3 locus when STAT3 was knocked down, and overexpression of STAT5 led to an increased number of Treg cells but a decreased number of Th17 cells in ACS patients. Our findings demonstrate that modulation of STAT3/STAT5 activity rectifies the imbalance of Th17/Treg cells in ACS patients. (C) 2015 Elsevier Inc. All rights reserved.
机译:信号转导和转录激活因子(STAT)的活性在急性冠脉综合征(ACS)患者Th17和Treg细胞的分化和失衡中起着重要作用。我们确定ACS患者的基础STAT3磷酸化水平显着升高,并与Th17细胞呈正相关,但与Treg细胞呈负相关。观察到STAT5活性相反的作用。在ACS患者中,使用药物抑制剂TG101348或抑制STAT3可以减少Th17细胞的数量,同时通过Janus激酶2(JAK2)/ STAT3途径促进Treg细胞的数量和功能。当STAT3被敲低时,更多的STAT5与Foxp3基因座结合,而STAT5的过表达导致ACS患者Treg细胞数量增加,而Th17细胞数量减少。我们的研究结果表明,STAT3 / STAT5活性的调节可纠正ACS患者Th17 / Treg细胞的失衡。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号